Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$257K Sell
5,202
-328
-6% -$15.8K 0.09% 193
2020
Q4
$269K Buy
5,530
+47
+0.9% +$2.32K 0.1% 157
2020
Q3
$275K Sell
5,483
-3,092
-36% -$159K 0.13% 114
2020
Q2
$438K Buy
+8,575
New +$417K 0.21% 74
2019
Q3
Sell
-68
Closed -$2.94K 519
2019
Q2
$2.94K Sell
68
-57
-46% -$2.42K ﹤0.01% 453
2019
Q1
$6K Buy
+125
New +$5.35K 0.22% 22

Other funds holding SNY

WealthStone's SNY Position: Q1 2021 in Review

WealthStone reduced its Sanofi (SNY) stake by 5.9% in Q1 2021, selling an estimated $15.8K and leaving 5,202 shares worth $257K. The position accounts for 0.09% of the portfolio, ranked #193.

WealthStone first reported a position in SNY in Q1 2019 and has held it in 6 quarters since. The position peaked at $438K in Q2 2020. 572 funds tracked by Wall St. Rank hold SNY as of Q1 2021.

  • WealthStone held 5,202 shares of Sanofi worth $257K as of Q1 2021.
  • WealthStone sold 328 Sanofi shares in Q1 2021, an estimated $15.8K.
  • Sanofi made up 0.09% of WealthStone's portfolio in Q1 2021, its #193 holding.
  • WealthStone first reported a position in Sanofi in Q1 2019 and has held it in 6 quarters since.
  • WealthStone's Sanofi position peaked at $438K in Q2 2020.
  • 572 funds tracked by Wall St. Rank held Sanofi as of Q1 2021.

Based on WealthStone's 13F filing for Q1 2021, filed 13 May 2021.